This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Mar 1;20(5):1164-6.

doi: 10.1200/JCO.2002.20.5.1164.

Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posed

Angela DeMichele, Barbara L Weber

PMID: 11870156
DOI: 10.1200/JCO.2002.20.5.1164

Editorial

Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posed

Angela DeMichele et al. J Clin Oncol. 2002.

. 2002 Mar 1;20(5):1164-6.

doi: 10.1200/JCO.2002.20.5.1164.

Authors

Angela DeMichele, Barbara L Weber

PMID: 11870156
DOI: 10.1200/JCO.2002.20.5.1164

No abstract available

PubMed Disclaimer

Comment on

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Scheuer L, et al. J Clin Oncol. 2002 Mar 1;20(5):1260-8. doi: 10.1200/JCO.2002.20.5.1260. J Clin Oncol. 2002. PMID: 11870168

Similar articles

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers.
Fakkert IE, Mourits MJ, Jansen L, van der Kolk DM, Meijer K, Oosterwijk JC, van der Vegt B, Greuter MJ, de Bock GH. Fakkert IE, et al. Cancer Prev Res (Phila). 2012 Nov;5(11):1291-7. doi: 10.1158/1940-6207.CAPR-12-0190. Epub 2012 Sep 25. Cancer Prev Res (Phila). 2012. PMID: 23009828
Clinical management of BRCA1 and BRCA2 mutation carriers.
Domchek SM, Armstrong K, Weber BL. Domchek SM, et al. Nat Clin Pract Oncol. 2006 Jan;3(1):2-3. doi: 10.1038/ncponc0384. Nat Clin Pract Oncol. 2006. PMID: 16407858 No abstract available.
Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?
Phillips KA, Lindeman GJ. Phillips KA, et al. Future Oncol. 2014 Mar;10(4):499-502. doi: 10.2217/fon.13.278. Future Oncol. 2014. PMID: 24754577 No abstract available.
Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.
Pierce L. Pierce L. Semin Radiat Oncol. 2002 Oct;12(4):352-61. doi: 10.1053/srao.2002.35254. Semin Radiat Oncol. 2002. PMID: 12382193 Review.
Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
Calderon-Margalit R, Paltiel O. Calderon-Margalit R, et al. Int J Cancer. 2004 Nov 10;112(3):357-64. doi: 10.1002/ijc.20429. Int J Cancer. 2004. PMID: 15382059 Review.

See all similar articles

Cited by

Women with BRCA1 or BRCA2 mutations renegotiating a post-prophylactic mastectomy identity: self-image and self-disclosure.
Kenen RH, Shapiro PJ, Hantsoo L, Friedman S, Coyne JC. Kenen RH, et al. J Genet Couns. 2007 Dec;16(6):789-98. doi: 10.1007/s10897-007-9112-5. Epub 2007 Oct 5. J Genet Couns. 2007. PMID: 17917796
Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
Cheon JY, Mozersky J, Cook-Deegan R. Cheon JY, et al. Genome Med. 2014 Dec 19;6(12):121. doi: 10.1186/s13073-014-0121-3. eCollection 2014. Genome Med. 2014. PMID: 25593598 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal